Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Merck
Farmers Insurance
Cerilliant
Colorcon
Chinese Patent Office
Accenture
Federal Trade Commission
AstraZeneca
US Department of Justice

Generated: January 16, 2018

DrugPatentWatch Database Preview

PROSCAR Drug Profile

« Back to Dashboard

When do Proscar patents expire, and when can generic versions of Proscar launch?

Proscar is a drug marketed by Merck and is included in one NDA. There is one patent protecting this drug.

This drug has six patent family members in five countries.

The generic ingredient in PROSCAR is finasteride. There are fourteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the finasteride profile page.
Drug patent expirations by year for PROSCAR
Pharmacology for PROSCAR
Medical Subject Heading (MeSH) Categories for PROSCAR

US Patents and Regulatory Information for PROSCAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for PROSCAR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 ➤ Subscribe ➤ Subscribe
Merck PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 ➤ Subscribe ➤ Subscribe
Merck PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 ➤ Subscribe ➤ Subscribe
Merck PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Healthtrust
Baxter
Cantor Fitzgerald
Julphar
Deloitte
Farmers Insurance
AstraZeneca
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot